AC-21-IE62_0.1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.1uM, Mitoguazone, Polyamine Biosynthesis Inhibitors;S-Adenosyl-L-methionine Decarboxylase Inhibitors targeting AMD1 (Novartis, 5351154)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/5351154
Similar Terms
Downloads & Tools

Genes

19 genes differentially expressed following the AC-21-IE62_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
RPL32 ribosomal protein L32 1.43129
MYL6 myosin, light chain 6, alkali, smooth muscle and non-muscle 1.19679
UBE2C ubiquitin-conjugating enzyme E2C 0.896197
SERP1 stress-associated endoplasmic reticulum protein 1 0.710433
CHRNB2 cholinergic receptor, nicotinic, beta 2 (neuronal) 0.476851
RPLP2 ribosomal protein, large, P2 0.458894
ZMPSTE24 zinc metallopeptidase STE24 0.458894
NTMT1 N-terminal Xaa-Pro-Lys N-methyltransferase 1 0.456994
RPL41 ribosomal protein L41 0.427086
CD300LB CD300 molecule-like family member b 0.42573
RPS10-NUDT3 RPS10-NUDT3 readthrough 0.334878
ROMO1 reactive oxygen species modulator 1 0.314037
PRRX2 paired related homeobox 2 0.28073
RPL37 ribosomal protein L37 0.28073
TGFB1I1 transforming growth factor beta 1 induced transcript 1 0.278113
RRP7A ribosomal RNA processing 7 homolog A (S. cerevisiae) 0.271169
NT5DC2 5'-nucleotidase domain containing 2 0.219656
PPDPF pancreatic progenitor cell differentiation and proliferation factor 0.206414
LGALS1 lectin, galactoside-binding, soluble, 1 0.203629